Harley Street’s London Alzheimer’s Clinic will be offering Transcranial Pulse Stimulation (TPS). TPS works by passing short and painless acoustic waves through a patient’s head to stimulate deep cerebral regions of the brain with millimetre accuracy. The waves then stimulate neural growth factors, which helps with the development and survival of nerve cells.
This also promotes the formation of new blood vessels and improved blood circulation.
Studies by researchers at the University of Vienna have indicated that just six 30-minute treatments over two weeks can improve mild to moderate Alzheimer’s by up to 10 points on the CERAD scale.
This is a measure of the progression of Alzheimer’s symptoms.
Patients and close relatives who received the treatment through the study have reported noticeable improvements in memory and verbal communication.
This has also led to an increase in social interaction.
Some patients further reported an improved sense of direction that allowed them to do their daily tasks independently.
Some were also able to safely find their way home afterwards.
Lead researcher Dr Roland Beisteiner says: “For the first time in the world, TPS enables us to penetrate into all areas of the brain by means of an ultrasound pulse delivered directly to the skull in a non-invasive, painless procedure, during which the patient is fully conscious, and to specifically target particular areas of the brain and stimulate them.”
The procedure has been described as painless and non-invasive.
With the new treatment now available at a London clinic, there also plans for it to be rolled out in Leeds and Hampshire clinics within the next few months.
Research conducted in 2019 shows that there were over 850,000 people with dementia in the UK, according to Alzheimer’s Society.
This represents one in every 14 of the population aged 65 years and over. In 2040, there will be over 1.5 million people with dementia in the UK, at the current rate of prevalence.
The number of people with dementia in the UK is forecast to increase to over two million by 2051.
Alzheimer’s disease is the most common type of dementia, affecting between 50 and 75 percent of those diagnosed.
And 209,600 people will develop dementia this year, that’s one every three minutes.